Dr. Patterson’s paper being published is a big deal. Its
Dr. Patterson’s paper being published is a big deal. Its big for the doctors to know what effect Leronlimab is having on Covid from our first study and how the lab results correspond with the effective anecdotal results. The viral load went to zero after the second dose. No other drug has results like this.
As for seeing a result in the stock price from the journal paper being printed. It’s up to Cytodyn to blow this up with press releases that allow the public to see and follow our trial. The press will help to get the word out but we need national exposure and this is important enough to get the main stream media’s attention. Then with what we had as an interim look and it showed very promising to continue the trial and meeting our main end point. That it’s quite possible that our next interim look will stop the trial and seek a EUA.
I am not the person to push the media or articles needed. We should have a media group hired to promote us. You might of heard of them? I hear so little from them I can’t keep straight which one we are with anymore. Not a good sign huh? Cytodyn has fired a few media companies that promote us. Hopefully we find the right company to promote our excellent results that we all know about but nobody else does. Someday we will have our own media person to do this. When we become a Pharmaceutical company with revenue. We are getting closer. It’s just a matter of a little more time.
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...
Continue Reading
The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...
Continue Reading
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue Reading
Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...
Continue Reading
Top 5 Most Recently Viewed Articles
XPENG Unveils the All-New P7 Sports Sedan XPENG has recently captured the attention of the automotive industry by unveiling the first images of its next-generation P7 sports sedan, a stunning evolution of its well-respected electric vehicle. This latest model embodies a daring and emotionally resonant design, continuing the company's commitment to excellence in the...
Continue Reading
Millicom's Share Repurchase Initiative Millicom, a leading telecommunications provider known for its dedication to enhancing shareholder value, recently launched a share repurchase program. This initiative, announced on a significant date, sets the stage for Millicom to strengthen its financial position and reward its investors more effectively. Details of the Share...
Continue Reading
TransformativeMed Forms Strategic Partnership with Vantiq TransformativeMed Now Positioned as Go-To Platform for Intelligent Systems and AI Leadership TransformativeMed, known for its exceptional CORES Platform, has established a strategic collaboration with Vantiq, a global leader in real-time AI and intelligent systems platforms. This partnership aims to position...
Continue Reading
The Row's Ambitious Next Steps The Row, an innovative mixed-use development, is on the brink of a transformative phase, focusing on enriching the far southeast area with vibrant retail, dining, and hotel options. This community-driven effort aims to elevate the quality of living for residents while creating a bustling hub for visitors. New Name, New Vision Previously...
Continue Reading
Introduction to Carbon Capture Technologies The carbon capture, utilization, and storage (CCUS) market offers an exciting glimpse into the future of energy sustainability. As the world increasingly confronts the challenges of climate change, new innovations in CCUS are becoming vital. Experts anticipate that this market will expand significantly, with projections...
Continue Reading